Bionano Genomics, Inc. (BNGO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 8.33M |
| Enterprise Value | 12.26M |
| P/E Ratio | -0.2 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.46 |
| Price/Book Ratio | 0.17 |
| Enterprise/Revenue | 0.57 |
| Enterprise/EBITDA | -0.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.1 |
| Operating Margin | -1.14 |
| Return On Assets | -0.49 |
| Return On Equity | -0.71 |
| Revenue | 28.51M |
| Revenue/Share | 5.28 |
| Gross Profit | 6.26M |
| EBITDA | -16.3M |
| Net Income | -26.4M |
| Diluted EPS | -4.85 |
| Total Cash | 24.67M |
| Total Cash/Share | 4.53 |
| Total Debt | 17.01M |
| Total Debt/Equity | 0.45 |
| Current Ratio | 1.84 |
| Book Value Per Share | 6.88 |
| 52-Week Change | -64.89 |
| 52-Week High | 5.5 |
| 52-Week Low | 1.06 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 1.54 |
| Average Volume | 190,232 |
| Shares Outstanding | 11.48M |
| % Held by Institutions | 15.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:60 |
| Last Split Date | January 27, 2025 |